Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Drug Manufacturers
Genomma Lab Internacional SAB de CV (GNMLF) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic Growth Initiatives
Genomma Lab Internacional SAB de CV (GNMLF) reports robust revenue growth, improved margins, and strategic expansions despite regional challenges. 7 days ago
Drug Manufacturers
Laurus Labs Ltd (BOM:540222) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives
Laurus Labs Ltd (BOM:540222) maintains strong gross margins and anticipates growth in its CDMO division despite facing revenue declines in key segments. 7 days ago
Drug Manufacturers
Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive Challenges
Indivior PLC (INDV) reports a 13% increase in total net revenue and a 62% rise in adjusted operating profit, while navigating competitive pressures and strategic cost reductions. 7 days ago